Cargando…
Inactivation of tumor-specific CD8(+) CTLs by tumor-infiltrating tolerogenic dendritic cells
Cancer immunosurveillance failure is largely attributed to the insufficient activation of tumor-specific class I major histocompatibility complex (MHC) molecule (MHC-I)-restricted CD8(+) cytotoxic T lymphocytes (CTLs). DEC-205(+) dendritic cells (DCs), having the ability to cross-present, can presen...
Autores principales: | Harimoto, Hirotomo, Shimizu, Masumi, Nakagawa, Yohko, Nakatsuka, Katsuhisa, Wakabayashi, Ayako, Sakamoto, Choitsu, Takahashi, Hidemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806489/ https://www.ncbi.nlm.nih.gov/pubmed/24018532 http://dx.doi.org/10.1038/icb.2013.38 |
Ejemplares similares
-
Inactivation of tumor-specific CD8(+) CTLs by tumor-infiltrating tolerogenic dendritic cells
por: Harimoto, Hirotomo, et al.
Publicado: (2013) -
Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells
por: Moriya, Keiichi, et al.
Publicado: (2010) -
Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression
por: Masu, Takushi, et al.
Publicado: (2018) -
HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA
por: Wakabayashi, Ayako, et al.
Publicado: (2018) -
Molecular Imaging in Tracking Tumor-Specific Cytotoxic T Lymphocytes (CTLs)
por: Liu, Zhiyi, et al.
Publicado: (2014)